ABSTRACT: The aim of this study was to investigate the local production of proinflammatory cytokines, pain-related sensory innervation of dorsal-root ganglia (DRG), and spinal changes in a rat model of induced hip osteoarthritis (OA). Seventy-five Sprague-Dawley rats were used, including 25 controls and 50 injected into the right hip joints (sham group, injected with 25 ml of sterile saline: N ¼ 25; and monosodium iodoacetate (MIA) group, injected with 25 ml of sterile saline with 2 mg of MIA: N ¼ 25). We measured the local production of TNF-a, immunoreactive (-ir) neurons for calcitonin gene-related peptide (CGRP), and growth associated protein-43 (GAP-43) in DRG, and immunoreactive neurons for ionized-calcium-binding adaptor molecule-1 (Iba-1) in the dorsal horn of spinal cord, on post-induction days 7, 14, 28, 42, and 56 (N ¼ 5 rats/group/time point). For post-induction days 7-42, the MIA group presented significantly elevated concentrations of TNF-a than the other groups (p < 0.01), and a higher expression of CGRP-ir in FG-labeled DRG neurons than the sham group (p < 0.01). MIA rats also presented significantly more FG-labeled GAP-43-ir DRG neurons than the sham group on post-induction days 28, 42, and 56 (p < 0.05), and a significantly higher number of Iba-1-ir microglia in the ipsilateral dorsal horn than the other groups, on post-induction days 28, 42, and 56. The results suggest that in rat models, pain-related pathologies due to MIA-induced hip OA, originate from inflammation caused by cytokines, which leads to progressive, chronic neuronal damage that may cause neuropathic pain.
Osteoarthritis (OA) is a major musculoskeletal disorder that affects at least 50% of the elderly population, 1 with hip and knee OA ranked as considerable contributors to global disability. 2 Pain is the main symptom in osteoarthritis, occurring more commonly than stiffness or disability. 3 In many countries, the increasing prevalence of OA is causing a dramatic number of people to suffer from chronic pain, which creates a huge burden. Nevertheless, joint pain pathophysiology received little attention for many years, compared to extensive research on inflammation and immunity in joint diseases, 4 and many important research questions remain unresolved. In recent years, researchers have been exploring the underlying pathophysiology of OA pain using animal models, 5 showing that it comprises a mixed phenomenon involving both nociceptive and neuropathic mechanisms at local and central levels. 6 Several studies support the notion that neuropathic pain mechanisms contribute to OA pain. [7] [8] [9] [10] [11] Most experiments have been conducted using knee OA models, such as anterior cruciate ligament transection, 12 partial medial meniscectomy, 13 or a combination of both.
14 Among them, the chondrocyte glycolytic inhibitor mono-iodoacetate (MIA) has been commonly used to create a chemically induced OA model in rats, through an intra-articular injection into the knee, 5, 15 which produces a pathology similar to OA. 15 The application of an intra-articular MIA injection to the hip joint was recently reported. 16 Previous studies report that, in the knee MIA-induced OA model, pain can originate from an inflammatory state induced by proinflammatory cytokines, which will be followed by gradual initiation of neuronal injury, leading, in turn, to a neuropathic pain state. 17 The initial inflammatory state is considered to be local, such as that in the synovial membrane which promotes pathological OA, and is followed by the production of several cytokines such as tumor necrosis factor (TNF)-a, interleukins (ILs), and nerve growth factor (NGF). TNF-a activates sensory neurons directly via its receptors and initiates a cascade of inflammatory reactions through the production of Ils. 18, 19 In addition, evaluation of the dorsal root ganglia (DRG) is also important to comprehend the pain pathology. Small DRG neurons containing painrelated neuropeptides, such as substance P and calcitonin gene-related peptide (CGRP), are related to acute inflammatory pain, 20, 21 and growth associated protein 43 (GAP-43) is reported to be a selective molecular marker for axon regeneration after nerve injury. 22 Chronic neuropathic pain increases the expression of GAP-43-immunoreactive (-ir) in DRG neurons in MIA-induced knee OA models. 17, 23 However, few studies analyzed the expression of these molecules in hip OA animal models. Furthermore, it is important to investigate OA at the level of the spinal cord, where glial cells such as microglia play an important role for neuropathic pain. 24 The expression of the ionized-calcium-binding adapter molecule 1 (Iba-1), the most common markers for microglia, immunoreactive microglia in the dorsal horn of spinal cord increases after neural injury. 25, 26 However, to our knowledge, no related studies have evaluated the time course of these findings in the spinal cord of animal models of MIA-induced hip OA. The purpose of this study was to investigate the local production of proinflammatory cytokines, the pain-related sensory innervation of dorsal-root ganglia, and the spinal changes in the MIA-induced hip OA rat model.
METHODS
All research protocols in this study were reviewed and approved by the ethics committee of our institution, and were performed in compliance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals (2010 revision).
Intra-Articular Injection of MIA and Retrograde Neurotracing
Seventy-five male, 6-week-old, Sprague-Dawley rats, weighing 200-300 g, were prepared (CLEA, Tokyo, Japan). Throughout the study, the rats were housed in a semi-barrier system with a controlled environment (12 h/12 h light/dark cycle; temperature: 21-23˚C; humidity: 45-65%). All rats were fed a diet of standard rodent chow (CRF-1; Oriental Yeast Co., Ltd., Tokyo, Japan). Based on methods previously published, 27 all rats were anesthetized with an intraperitoneal injection of 0.3 mg/ kg of medetomidine, 4.0 mg/kg of midazolam, and 5.0 mg/kg of butorphanol and treated aseptically throughout the experiments. Using a 27-gauge needle, the following solutions were injected into the right hip joint of each rat using a posterior approach 16, 28 : 25 ml of sterile saline with 2 mg of MIA (SigmaAldrich, St. Louis, MO) and 1% of the retrograde neurotracer FG (Fluorochrome, Denver, CO) in the MIA group rats (N ¼ 25), and 25 ml of sterile saline with 1% of the retrograde neurotracer FG in the sham group rats (N ¼ 25). The injected fluid was confirmed to be restricted to the joint cavity. The used MIA doses were according to previously published protocols. 16, 23, 29 No injections were performed on the control group (N ¼ 25). To evaluate the effect of invasion of the posterior approach itself, we used the control group in which no procedures were performed.
X-Ray Imaging of the Hip Joint and Tissue Preparation X-ray imaging of the hip joint and tissue preparations were performed as previously described by Miyamoto et al. 16 using an in vivo imager (Xtreme, Bruker, WI). For histological evaluation, the samples were stained using hematoxylin and eosin (H-E), Safranin O, and Toluidine Blue.
Cytokine Enzyme-Linked Immunosorbent Assay (ELISA) of the Local Tissues Samples were obtained at post-induction days 7, 14, 28, 42, and 56, from five rats of each group, per time point. The trimmed samples of soft tissue from inside the hip, proliferated synovial membrane, and anterior to posterior capsule of the ipsilateral hips, were cut into pieces of about 1 mm Â 1 mm Â 2 mm in size, well-rinsed in PBS, frozen in liquid nitrogen, and then crushed into powder and homogenized in a 300 ml lysis buffer (Cell Destroyer, Bioprep-24 version, Hangzhou Allsheng Instruments, Zhejiang, China). The samples were centrifuged for 20 min at 13,000 rpm for 20 min at 4˚C, and the supernatants were extracted for the assay. The concentrations of TNF-a were measured using ELISA kits (Abcam, Cambridge, UK), and the procedure was performed according to the manufacturer's instructions. After being measured with a microplate reader (Iwaki, Tokyo, Japan), the absolute cytokine concentrations were converted into the corresponding concentrations per mg of total protein.
Immunohistochemistry of the DRG and Spinal Cord Specimens
Samples were prepared on post-induction days 7, 14, 28, 42, and 56, in five rats of the MIA and sham groups. After deep anesthesia, the rats were perfused intracardially with 0.9% saline, followed by 500 ml of 4% paraformaldehyde in phosphate-buffer (0.1 M, pH 7.4). The right side DRGs of L4 were resected and prepared for immunohistochemistry. The DRG and spinal cord specimens were immersed in the phosphatebuffered paraformaldehyde overnight, at 4˚C. After storage in 0.01 M phosphate-buffered saline (PBS) containing 20% sucrose for 20 h at 4˚C, they were frozen in liquid nitrogen. Using a cryostat, each DRG was sectioned at 10 mm and the spinal cord at 30 mm (Leica Microsystems, CM3050S, Wetzlar, Germany), after which the sections were mounted on poly-Llysine-coated slides. The specimens were then treated at room temperature with a blocking solution for nonspecific binding sites, consisting of PBS containing 0.3% Triton X-100 and 3% skim milk for 90 min. They were processed for CGRP immunohistochemistry using rabbit antibody against CGRP (1:1,000; Chemicon, Temecula, CA), or for GAP-43 immunohistochemistry using a mouse antibody against GAP-43 (1:1,000, Millipore, Danvers, MA). The spinal cord specimens were processed using a rabbit antibody against Iba-1 (1:1,000; Wako, Osaka, Japan). After incubation with the diluted antibodies for 20 h at 4˚C, DRG sections were incubated with Alexa 488-conjugated goat anti-rabbit IgG (for CGRP immunoreactivity, 1:1,000; Molecular Probes, Eugenem, OR), and Alexa 594-conjugated goat anti-mouse IgG (for GAP43 immunoreactivity, 1:1,000; Molecular Probes). Spinal cord specimens were incubated with Alexa 488-conjugated goat anti-rabbit IgG (for Iba-1 immunoreactivity, 1:1,000). After each step, the sections were rinsed three times in PBS. The immunostained sections were observed using a fluorescence microscope (Olympus, Tokyo, Japan), in a treatment-blinded manner. The numbers of FGlabeled CGRP-ir DRG neurons and FG-labeled GAP-43-ir DRG neurons were counted by blinded observers, and their proportion to the total number of FG-labeled DRG neurons was calculated for each DRG sample. The number of Iba-1-ir dorsal horn neurons per 0.1 mm 2 was counted using a counting grid. Three skilled observers evaluated positive staining. If there was an agreement between at least two of the observers, the evaluation was accepted.
Statistical Analysis
Values were presented as the mean AE standard deviation. Statistical analysis was performed using JMP 1 Pro 12 (SAS Institute Inc., Cary, NC). The cytokine concentrations were evaluated using a Tukey-Kramer test. The proportions of CGRP-ir and GAP-43-ir FG-labeled neurons in the DRGs were compared using a Mann-Whitney U-test. Comparisons of the number of Iba-1-ir neurons between groups were made using a Steel-Dwass test. A p-value <0.05 was considered significant.
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RESULTS
Local X-Ray and Histopathological Findings
The MIA group presented progressive OA changes, whereas the sham group maintained a normal appearance ( Figs. 1 and 2 ). The OA changes were detected post-induction day 14, and consisted of possible joint space narrowing (JSN), cystic changes in the femoral head in the X-ray, and extensive collapse of the cartilaginous matrix with a marked loss of chondrocytes. On day 28 post-induction, the MIA group radiographically exhibited definite JSN, flattening of the femoral head, and histologically shrunken chondrocytes with a marked loss of cellular detail. By day 56 post-induction, most of the articular cartilage had disappeared and the articular surface was exposed, with a prominent loss of height.
ELISA of the Local Tissues
On days 7-42 post-induction, the modified concentrations of TNF-a in the MIA group were significantly elevated compared with other groups (p < 0.01, Fig. 3 ), and they decreased gradually as the post-induction period progressed. On day 56, there was a significant difference between the MIA and control groups (p < 0.05).
Immunohistochemistry
Expression of CGRP and GAP43-ir Neurons
On days 7-42 post-induction, the MIA group presented a higher expression of FG-labeled CGRP-ir DRG neurons group than the sham group (p < 0.01, Fig. 4) , and on post-induction days 28, 42, and 56 the MIA group presented significantly more FG-labeled GAP-43-ir DRG neurons in L4 than the sham group (days 28 and 42: p < 0.05, day 56: p < 0.01 Fig. 5 ). GAP-43-ir DRG neurons were not observed in the MIA group on days 7 and 14 or in the sham group rats throughout the period examined.
Expression of Iba1-ir Microglia in the Dorsal Horn of the Spinal Cord Iba1-ir microglia were observed in dorsal horns bilaterally (Fig. 6) , with those in the ipsilateral dorsal horn showing higher proliferation and hypertrophy (Fig. 6B) , compared with those on the contralateral side (Fig. 6A) . The number of microglia in the ipsilateral dorsal horn was significantly higher than those of the sham and control groups on post-induction days 28, 42, and 56. (Fig. 6D) (p < 0.01) .
DISCUSSION
In the current study, the OA changes were detected post-induction day 14 in the MIA group and they presented progressive OA changes over time. MIA has been reported to cause joint pathology by inhibiting glycolysis, thereby targeting avascular cartilage and causing chondrocyte death. 17 Udo et al. 30 have reported that MIA-induced degenerative changes of cartilage and bone depend on time. In the MIA-induced knee OA model, histological examination revealed chondrocyte degeneration and necrosis at days 1-7 after induction, increased osteoclasts and osteoblasts in the subchondral bone by day 7, focal fragmentation and collapse of bony trabeculae with fibrosis by day 28, and large areas of bone remodeling by day 56. 31 MIA induced synovitis, which lasted 3 days after induction; this was followed by the thinning of the articular cartilage and subsequent lesion of the subchondral bone at days 8-14 onward. 32 Activated chondrocytes and synovial membranes are major sources of elevated proinflammatory mediators, among which TNF-a produced from the activated chondrocytes or synovial membranes can induce IL-6 upregulation. It has also been reported that IL-6 enhances TNF-a-receptor expression 17 ; thus, these proinflammatory mediators act in harmony to trigger further inflammation. Following the inflammatory period, a significant increase in angiogenesis was observed in the animal model at week 5 but not at week 2 after injection. In human OA, synovial neovascularization is frequently accompanied by synovitis and largely driven by the secretion of angiogenic factors, including VEGF and proinflammatory cytokines, by lymphocytes, which initiates a positive feedback loop. 33 Other proinflammatory cytokines, including IL-7, IL-17, and IL-18, have also been implicated in synovitis, subchondral bone damage, and cartilage homeostasis alteration. Blood vessel growth may contribute to inflammation and structural disease progression because of its role in endochondral ossification. Furthermore, it has been demonstrated that mechanical stimulation can increase the chondrocyte production of reactive oxygen species, which depolymerize hyaluronic acid and kill chondrocytes. 34 Moreover, Green et al. 35 have demonstrated that injured cartilage is more susceptible to further leukocyte-mediated injuries. These studies may help in further elucidating the development of OA. 35 The production of TNF-a in the MIA group showed temporal increase from 7 to 42 days post-induction, and it decreased gradually as the post-induction period progressed. Concerning the MIA-induced knee OA model, Orita et al. stated that an intra-articular MIA injection significantly increased TNF-a in the knee synovium and capsule between days 1 and 28 after MIA injection, and the levels of TNF-a peaked at day 4. 17 However, there have been no studies on proinflammatory cytokines in the MIA-induced hip OA model so far. TNF-a is known as one of the major proinflammatory cytokines responsible for cartilage destruction in OA, 36 exerting a possible catabolic effect that contributes to the pathophysiological progression of OA. 37 TNF-a is also closely involved in pain. When injected into the knee joint of healthy animal models, TNF-a significantly and persistently sensitizes the nociceptive sensory fibers to mechanical stimuli, which improves dramatically by co-administration of a TNFa inhibitor, and by TNF-a induced excitation of isolated DRG neurons with C-fiber axons. 38 In a clinical setting, TNF-a is related to pain intensity rather than dysfunction. 39 Thus, investigating TNF-a in the hip joint is important to comprehend the pathology of hip OA. The current report describes, for the first time, the changes in proinflammatory cytokines following MIA-induction of hip OA in rats.
The expression of FG-labeled CGRP-ir DRG neurons was significantly higher in the MIA group than in the sham group on days 7, 14, 28, and 42 post-induction. On the contrary, there were significantly more FG-labeled GAP-43-ir DRG neurons in the L4 in the MIA group than in the sham group during the late phase of the post-induction period, that is, from days 28 to 56. Previous studies have revealed that the hip joint is majorly innervated from the ipsilateral L4 DRG. 40, 41 Miyamoto reported similar findings in that the expression of FG-labeled CGRP-ir neurons in the ipsilateral 
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DRG increased from days 7 to 42 post-induction. 40 In addition, CGRP-ir DRG neurons in a rat model of hip OA induced by NGF also increased from day 7.
28 CGRPir DRG neurons have been reported to be NGF-dependent and involved in inflammatory pain perception, 42 suggesting that CGRP is a marker of inflammatory pain. In rats, the pain signal from the hip is mainly transmitted by CGRP-ir DRG neurons. 41 Our results suggest that an elevation of CGRP expression indicates an early phase of local inflammation, and it may continue for 42 days.
On the other hand, GAP-43 was expressed in the late phase after MIA injection. GAP-43 is a selective molecular marker for axon regeneration after nerve injury, 22 thus the increased expression of GAP-43-ir DRG neurons implies the evidence of gradual nerve regeneration after nerve injury, which may result from cartilage degeneration. The physical wearing of cartilage causes the exposure of subchondral bone, where pain-related sensory nerve ingrowth and respective mediators increase. 43 Then, the exposed nerve endings may become physically injured, which can accelerate nerve ingrowth into the subchondral bone. This can generate the temporally increased expression of GAP-43. In clinical studies, it has also been proposed that sensory nerve elongation may occur in the synovial tissue of OA patients. 44, 45 In the current study, the administration of MIA to the hip joint in rats provoked the degeneration of the cartilage, starting to expose the subchondral bone from post-induction day 14. 16 The nerve elongation from subchondral area to joint and nerve damage occurred subsequently, leading to a nerve regeneration phase. Our results reflect this time course. A previous study reported that the activating transcription factor-3 (ATF-3), a selective marker of cell damage following nerve injury, was observed not during the acute phase but during the late phase after MIA injection to hip joint in rats. 40 This result is similar to that obtained in models of MIA-induced knee OA, 17, 23 and suggests that neuropathic pain partly contributes to OA pain.
In the current study, the number of microglia in the ipsilateral dorsal horn was significantly higher than those of the sham and control groups from day 28 postinduction. This time course in microglia proliferation corresponded to that in GAP-43 expression. Therefore, peripheral neural injury may have some effect on central nervous sensitization, which has not been investigated in the MIA-induced hip OA model yet. As for knee MIA-induced model, previous studies report that significant proliferation of microglia in the ipsilateral dorsal horn occurs from days 14 to 28, 17, 46 where glial cells in the spinal cord, such as microglia and astrocytes, respond to peripheral tissue injury by proliferating, presenting antigens, and releasing mediators which contribute to dorsal horn mechanisms of chronic pain. 47, 48 It is also known that microglia are activated earlier in the direct nerve injury model than in MIA-induced OA models. 49, 50 This supports our findings that neuropathic pain occurs in the late phase after the acute inflammatory phase. The MIA-induced OA pain results from inflammation, which initiates an inflammatory pain state, and subsequent neural damage gradually caused by progressive cartilage degeneration may lead to chronic neuropathic pain. This may have important implications for targeted analgesic therapies in future. In addition to anti-inflammatory therapies, such as NSAIDs, which may be mainly effective for patients with OA in the early phase, treatment for neuropathic pain should be considered for patients with moderate-to-severe OA. As the mechanism of OA pain is complex and not fully understood, further experiments are needed to clarify the pathology and develop protocols for the treatment for OA pain in the future.
It is possible that MIA-induced OA model might be different from chronic hip OA like human hip OA, particularly in cartilage morphology and radiographic deformity. In the previous report on MIA-induced knee OA model, 51 both MIA-induced and secondary hip OA included chondrocyte degradation and showed an appearance of type II collagen fibers; however, chondropathy was qualitatively more extensive in the MIA-induced OA than in the secondary OA. Rats with secondary OA also present with an increased osteophyte complex formation to compensate for the mechanical instability and concentrated stress. DRGs and the spinal cord share several common features associated with the sensitization of primary somatosensory pathways. However, in the MIA-induced knee OA model, it has been reported that allodynia and hyperalgesia are more prevalent in chemical models that use >2 mg of MIA than in surgical models. 52 Further, Brederson et al. 51 have reported increased p38 and pERK expressions in the spinal cord of MIA-OA rats but not in that of surgically induced rats. Conversely, both chemical and surgical models for OA-induced pain exhibited similar gene expression patterns in DRGs. 33, 51 Thus, similar results are theoretically obtainable in the hip OA model. However, although the hip joint is a ball joint, it is mechanically different from the knee joint. Further reports are expected in the future. Currently, we are conducting research on creating a surgical OA model.
The current study has some limitations. First, it was unclear which type of OA was induced by the MIA injection into the rat hip. The knee MIAinduced OA model has been widely used in pain research because it is a rapid and easily reproducible method, and has similar histopathology to human knee OA. [53] [54] [55] However, it may be different from chronic hip OA in its pathogenesis, because the MIAinduced coxarthritis is rapidly destructive. It may be necessary to reconsider the dose of MIA and the duration of the observation period. Nevertheless, animal models of hip OA may help elucidate the pathology of hip pain, and may be essential for future research. Second, we only examined the TNFa but did not quantify other proinflammatory cytokines such as Ils and NGF. To further clarify the pathology of hip OA, it is necessary to understand the interactions between these cytokines. Third, the samples from each hip were complex structures consisting of synovium and capsules, and the distribution of proinflammatory cytokines in each structure was not examined. Finally, although we evaluated the proliferation and activation of microglia, we did not investigate pain-related behavior, which microglia are deeply involved in. However, our previous study describes significant pain-related behavior and gait disturbance in MIA-induced hip OA in rats, 34 which comprises a preliminary approach to that issue.
In conclusion, our study revealed the characteristics and time course of pain-related sensory innervation in an MIA-induced hip OA model. Proinflammatory cytokines and CGRP-ir DRG neurons increased in the early post-induction phase, and the expression of GAP-43-ir DRG neurons and proliferation and activation of microglial cells in the dorsal horn of the spinal cord were observed in the late phase. This suggests that pain-related characteristics in the MIA-induced hip OA model in rats are initially generated by an inflammatory pain state caused by proinflammatory cytokines, which will result in progressive and chronic neuronal damage that can cause neuropathic pain.
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